| MM | Multiple myeloma |
| IMiDs | Immunomodulatory drugs |
| TE | Thrombotic events |
| LMWH | Low molecular weight heparin |
| Thal | Thalidomide |
| Len | Lenalidomide |
| Pom | Pomalidomide |
| VTE | Venous thromboembolism |
| β2M | Beta-2 microglobulin |
| IMWG | International Myeloma Working Group |
| SA-PE | Streptavidin-phycoerythrin |
| ASA | Aspirin |
| MLR | Monocyte-to-lymphocyte ratio |
| DOAC | Direct oral anticoagulants |